FDA’s Lax Ways
Despite increasing calls for transparency at the FDA, the agency’s sloppy performance continues to put consumers at risk both medically and financially.
Despite increasing calls for transparency at the FDA, the agency’s sloppy performance continues to put consumers at risk both medically and financially.
The Massachusetts Public Health Emergency Preparation and Response Act (H4275) passed the House on 10.08.09. This piece of legislation articulates the authority granted to the Commissioner of the Department of Public Health during a ‘declared emergency’ and is companion legislation to S2028, which passed in April of this year. The two bills will now go […]
The natural-products community and nutritionally oriented practitioners are very familiar with media bias. For example, the press often reports that “dietary supplements are not regulated.”
We have previously written here about the ramifications of the economic stimulus bills that became law in February 2009. Putting aside the economic and security consequences of adding to the nation’s debt, let’s focus on the $1.1 billion for a Comparative Effectiveness Research (CER) program, designed to determine which healthcare treatment options are most effective […]
Now that the House is set to debate the merged healthcare bill, we need to make sure they get it right!
Those following the debate over healthcare reform often hear that eliminating waste from the current healthcare system would, in large measure, fund reform. Given the number of dollars wasted, the lives lost and the suffering associated with sloppy healthcare, why do we drag our feet in improving our current system and reducing waste?
Various labeling systems are currently being used by U.S. retailers and food makers to make nutritional claims. Barbara Schneeman, Ph.D., director of the FDA’s Office of Nutrition, Labeling and Dietary Supplements, recently sent an open letter to the food industry stating the agency’s intent to develop a new regulation to define “the nutritional criteria that […]
The public consciousness of risk vs. benefit was raised considerably with the media’s discussion of the benefits of taking a Cox II inhibitor (Celebrex and Vioxx) vs. the potential risks (Cox II inhibitors are linked to the risk of gastrointestinal bleeding as well to an increased risk of heart attack).
The legislators have sent House Speaker Nancy Pelosi, D-Calif., a letter proposing a ban on discrimination against integrative MDs, DOs, chiropractors and other well-trained and credentialed healthcare providers who have not previously been discriminated against under federal law. If discrimination is not forbidden, conventional licensed practitioners will try to use federal law, as they have […]
As the debate for healthcare reform continues inside the beltway, on the airwaves, and around many a dinner table and water cooler, how can we — a nation known for ingenuity and entrepreneurship — deliver quality care for a reasonable price? Former House Speaker Newt Gingrich, in his book Saving Lives, Saving Money, is but […]